LH - Company ID 0000920148
The table below shows LABORATORY CORP OF AMERICA HOLDINGS's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $3.81B | $3.73B | $3.54B | $3.56B | $3.53B | $3.35B |
| Cost of revenue | $2.70B | $2.62B | $2.52B | $2.54B | $2.48B | $2.40B |
| Gross profit | $1.11B | $1.11B | $1.01B | $1.03B | $1.05B | $948.00M |
| R&D | - | - | - | - | - | - |
LABORATORY CORP OF AMERICA HOLDINGS reported annual revenue of $13.95B for fiscal year 2025. That is up 7.2% from $13.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.55B (FY 2016) to $13.95B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $611.40M |
| $577.20M |
| $551.00M |
| $552.40M |
| $579.30M |
| $546.00M |
| Operating income | $402.10M | $451.60M | $380.80M | $396.60M | $394.50M | $326.00M |
| Income tax | $64.90M | $87.30M | $41.70M | $75.50M | $66.40M | $62.20M |
| Net income | $262.80M | $298.70M | $277.80M | $261.10M | $237.90M | $212.80M |
| EPS (diluted) | $3.22 | $3.64 | $3.35 | $3.12 | $2.84 | $2.52 |